Lifebank Corp.
TSX VENTURE : LBK

Lifebank Corp.

April 22, 2008 19:32 ET

Lifebank Corp. Becomes First Canadian Umbilical Cord Blood Stem Cell Bank to Exclusively Use a Sterile Field Cord Blood Collection Unit

BURNABY, BRITISH COLUMBIA--(Marketwire - April 22, 2008) - Lifebank Corp. ("Lifebank") (TSX VENTURE:LBK), one of Canada's most experienced and dedicated leaders in umbilical cord blood stem cell banking, announced today that it has begun exclusively providing a sterile field cord blood collection unit in every Lifebank collection kit. The new collection unit, produced by Pall Life Sciences (NYSE:PLL), is appropriate for use in any cord blood collection setting including caesarean section, vaginal birth, or ex utero cord blood collection. There is no need for additional extension sets or assembly at time of collection, providing health care professionals the ability to easily collect umbilical cord blood from newborns, even within the sterile surgical field of a caesarean section. The collection of umbilical cord blood is a critical step in the process of stem cell banking. The unique shape and components of this new collection unit allow for the safe and maximum recovery of cell-rich cord blood units.

"Since 1996 Lifebank has provided a service dedicated to quality," said Ernest Stacey, President & CEO of Lifebank. "The provision of this new cord blood collection unit, which received full endorsement from our Medical and Scientific Advisory Board, once again demonstrates to our clients and the medical community our continued commitment to quality and another Lifebank first for the Canadian medical community."

Roberto Perez, President of Pall Life Sciences added, "Lifebank's mission is to offer its clients the most current, clinically proven procedures available for the cryogenic storage of umbilical cord blood. We are honored that Pall cord blood collection technologies have been selected to play a critical part in this pursuit. We applaud Lifebank's tireless efforts to educate future parents that stem cells are a biological asset of incalculable value and willingness to invest in optimal technologies to preserve them."

Lifebank is a biomedical service company that provides processing and cryogenic (ultra low temperature) storage of umbilical cord blood stem cells. It is an AABB accredited, Health Canada inspected and FDA registered facility. Lifebank has successfully stored stem cell units for clients in Canada, the United States, Asia, Europe, the Middle East and the Caribbean. Lifebank is dedicated to providing its clients with the finest cord blood stem cell processing, analysis and cryogenic storage services available in the world. Lifebank strives to work closely with health care professionals and institutions in order to provide life saving cord blood services to any and all persons in need.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information